An antiviral that is currently in clinical trials stops Covid-19 in it's tracks, by preventing it from replicating. The end of viral replication neuters Covid-19.
If Remdesivir is shown to be non-toxic and safe for humans, this could be the WHOLE BALL GAME folks.
The maker of the anti-viral, Gilead Sciences in California, is ramping up production to provide multiple clinical trials in the U.S., Asia, and Europe. The U.S. Army also is testing the drug.
WE WILL KNOW THE RESULTS OF THE FIRST CLINICAL TRIAL IN A FEW WEEKS.